Literature DB >> 8699027

Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study.

J Mestecky1, R G Hamilton, C G Magnusson, R Jefferis, J P Vaerman, M Goodall, G G de Lange, I Moro, P Aucouturier, J Radl, C Cambiaso, C Silvain, J L Preud'homme, K Kusama, G M Carlone, J Biewenga, K Kobayashi, F Skvaril, C B Reimer.   

Abstract

51 monoclonal antibodies (McAb) with putative specificity for human IgA, the IgA subclasses, Am allotypes or secretory component (SC) were evaluated for immunoreactivity and specificity by nine laboratories employing immunodiffusion, agglutination, immunohistological assays, immunoblotting and direct binding and competitive inhibition enzyme immunoassays. McAbs specific for IgA PAN (n = 24), IgA1 (n = 7), IgA2 (n = 3), IgA2m(2) (n = 2), non-IgA2m(2) (n = 4) and SC or secretory IgA (n = 5) were identified that were immunoreactive and specific in the assays employed. The McAbs identified as IgA- or SC-reactive were shown to be non-reactive to human IgG, IgM, IgD, IgE, kappa and lambda by direct binding and competitive inhibition immunoassays. Interestingly, no McAbs with restricted specificity for IgA2m(1) were identified. Some McAbs displayed higher affinity and/or better performance in one or several of the assay groups. The IgA- and SC-specific McAbs identified in this international collaborative study have potential as immunochemical reference reagents to identify and quantitate monomeric and polymeric IgA in human serum and secretions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699027     DOI: 10.1016/0022-1759(95)00289-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Psychological distress and salivary secretory immunity.

Authors:  C G Engeland; F N Hugo; J B Hilgert; G G Nascimento; R Junges; H-J Lim; P T Marucha; J A Bosch
Journal:  Brain Behav Immun       Date:  2015-08-28       Impact factor: 7.217

2.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.

Authors:  Jennifer S Moore; Rose Kulhavy; Milan Tomana; Zina Moldoveanu; Hitoshi Suzuki; Rhubell Brown; Stacy Hall; Mogens Kilian; Knud Poulsen; Jiri Mestecky; Bruce A Julian; Jan Novak
Journal:  Mol Immunol       Date:  2007-02-02       Impact factor: 4.407

3.  Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of BALB/c mice.

Authors:  Fatemeh Ezzatifar; Jafar Majidi; Behzad Baradaran; Leili Aghebati Maleki; Jalal Abdolalizadeh; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-03-05

4.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Authors:  M Tomana; J Novak; B A Julian; K Matousovic; K Konecny; J Mestecky
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases.

Authors:  Margaret R Batten; Bernard W Senior; Mogens Kilian; Jenny M Woof
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

6.  Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1.

Authors:  Yoshinao Wada; Anne Dell; Stuart M Haslam; Bérangère Tissot; Kévin Canis; Parastoo Azadi; Malin Bäckström; Catherine E Costello; Gunnar C Hansson; Yoshiyuki Hiki; Mayumi Ishihara; Hiromi Ito; Kazuaki Kakehi; Niclas Karlsson; Catherine E Hayes; Koichi Kato; Nana Kawasaki; Kay-Hooi Khoo; Kunihiko Kobayashi; Daniel Kolarich; Akihiro Kondo; Carlito Lebrilla; Miyako Nakano; Hisashi Narimatsu; Jan Novak; Milos V Novotny; Erina Ohno; Nicolle H Packer; Elizabeth Palaima; Matthew B Renfrow; Michiko Tajiri; Kristina A Thomsson; Hirokazu Yagi; Shin-Yi Yu; Naoyuki Taniguchi
Journal:  Mol Cell Proteomics       Date:  2009-12-28       Impact factor: 5.911

7.  Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.

Authors:  Sian E Faustini; Sian E Jossi; Marisol Perez-Toledo; Adrian M Shields; Joel D Allen; Yasunori Watanabe; Maddy L Newby; Alex Cook; Carrie R Willcox; Mahboob Salim; Margaret Goodall; Jennifer L Heaney; Edith Marcial-Juarez; Gabriella L Morley; Barbara Torlinska; David C Wraith; Tonny V Veenith; Stephen Harding; Stephen Jolles; Mark J Ponsford; Tim Plant; Aarnoud Huissoon; Matthew K O'Shea; Benjamin E Willcox; Mark T Drayson; Max Crispin; Adam F Cunningham; Alex G Richter
Journal:  Immunology       Date:  2021-05-24       Impact factor: 7.215

8.  Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.

Authors:  I C Moura; M N Centelles; M Arcos-Fajardo; D M Malheiros; J F Collawn; M D Cooper; R C Monteiro
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

9.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Authors:  Jennifer M Dan; Jose Mateus; Yu Kato; Kathryn M Hastie; Esther Dawen Yu; Caterina E Faliti; Alba Grifoni; Sydney I Ramirez; Sonya Haupt; April Frazier; Catherine Nakao; Vamseedhar Rayaprolu; Stephen A Rawlings; Bjoern Peters; Florian Krammer; Viviana Simon; Erica Ollmann Saphire; Davey M Smith; Daniela Weiskopf; Alessandro Sette; Shane Crotty
Journal:  Science       Date:  2021-01-06       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.